Literature DB >> 19659420

Extracellular DNA and F-actin as targets in antibiofilm cystic fibrosis therapy.

Tim Tolker-Nielsen1, Niels Høiby.   

Abstract

Entities:  

Year:  2009        PMID： 19659420     DOI： 10.2217/fmb.09.38

Source DB:  PubMed          Journal:  Future Microbiol        ISSN： 1746-0913            Impact factor:   3.165


× No keyword cloud information.
  5 in total

1.  MicroRNA-144 dysregulates the transforming growth factor-β signaling cascade and contributes to the development of bronchiolitis obliterans syndrome after human lung transplantation.

Authors:  Zhongping Xu; Sabarinathan Ramachandran; Muthukumar Gunasekaran; Fangyu Zhou; Elbert Trulock; Daniel Kreisel; Ramsey Hachem; Thalachallour Mohanakumar
Journal:  J Heart Lung Transplant       Date:  2015-03-27       Impact factor: 10.247

2.  Why is Pseudomonas aeruginosa a pathogen?

Authors:  Joanna B Goldberg
Journal:  F1000 Biol Rep       Date:  2010-04-27

Review 3.  Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis.

Authors:  Niels Høiby
Journal:  BMC Med       Date:  2011-04-04       Impact factor: 8.775

4.  Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.

Authors:  Elena K Schneider-Futschik; Olivia K A Paulin; Daniel Hoyer; Kade D Roberts; James Ziogas; Mark A Baker; John Karas; Jian Li; Tony Velkov
Journal:  ACS Infect Dis       Date:  2018-04-02       Impact factor: 5.084

Review 5.  RNA-Dependent Regulation of Virulence in Pathogenic Bacteria.

Authors:  Shubham Chakravarty; Eric Massé
Journal:  Front Cell Infect Microbiol       Date:  2019-10-09       Impact factor: 5.293
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.